Flavohemoglobins metabolize nitric oxide (NO) to nitrate and protect bacteria and fungi from NO-mediated damage, growth inhibition, and killing by NO-releasing immune cells. Antimicrobial imidazoles were tested for their ability to coordinate flavohemoglobin and inhibit its NO dioxygenase (NOD) function. Miconazole, econazole, clotrimazole, and ketoconazole inhibited the NOD activity of Escherichia coli flavohemoglobin with apparent K i values of 80, 550, 1,300, and 5,000 nM, respectively. Saccharomyces cerevisiae, Candida albicans, and Alcaligenes eutrophus enzymes exhibited similar sensitivities to imidazoles. Imidazoles coordinated the heme iron atom, impaired ferric heme reduction, produced uncompetitive inhibition with respect to O 2 and NO, and inhibited NO metabolism by yeasts and bacteria. Nevertheless, these imidazoles were not sufficiently selective to fully mimic the NO-dependent growth stasis seen with NOD-deficient mutants. The results demonstrate a mechanism for NOD inhibition by imidazoles and suggest a target for imidazole engineering.
Nitric oxide (NO) is released by macrophages and other immune cells to poison and help eliminate infectious microbes, parasites, and tumor cells (12, 27, 41) . Diverse life forms protect against NO toxicity by expressing NO-metabolizing enzymes. NO dioxygenases (NODs) (EC 1.14.12.17) convert NO to NO 3 Ϫ (equation 1), while in some organisms NO reductases (NORs) (EC 1.7.99.7) reduce NO to N 2 O (equation 2) (18, 39, 64) . NODs utilize O 2 for NO detoxification, whereas NORs scavenge and detoxify NO under anaerobic conditions and supplement NOD under the microaerobic conditions found in infections (16) (17) (18) 20) .
Genomic microarrays of Escherichia coli, Bacillus subtilis, and Pseudomonas aeruginosa reveal NOD (hmp) and NOR gene transcription prominently induced by NO in vitro (37, 38) . Salmonella enterica expresses NOD (hmp) and NOR (norVW) gene transcripts at high levels in infected macrophages, indicating roles in adaptation to macrophage NO (10) . In addition, DNA microarrays of immune-resistant mucoid isolates of P. aeruginosa reveal NOD (fhb) and NOR (norBC) gene transcript levels elevated Ͼ50-fold, suggesting roles in the virulence of these P. aeruginosa strains (14) . Moreover, NODs have been shown to prevent NO-mediated growth inhibition of bacteria, yeasts, and fungi (4, 7, 15, 20, 25, 26, 31, 36, 46, 55) , decrease the susceptibility of Salmonella to killing by macrophages (51) , and modestly increase the virulence of Cryptococcus neoformans and Candida albicans in systemic infections of mice (7, 55) . NODs, NORs, and other microbial defense enzymes have thus emerged as attractive targets for antibiotic development (40) . Agents that selectively target microbial defenses are expected to generate antibiotic-resistant mutants at reduced frequencies given the coordinate production of myriad antimicrobial toxins including NO, H 2 O 2 , HOCl, and O 2 Ϫ during the innate immune response and the multiple sites for toxin actions (12, 20) .
The well-characterized flavohemoglobins (flavoHbs) and single domain hemoglobins (Hbs) with their associated reductases function as NODs in a variety of human and plant pathogens, including E. coli, S. enterica serovar Typhimurium, C. albicans, C. neoformans, Klebsiella pneumonia, P. aeruginosa, Mycobacterium tuberculosis, and Erwinia chrysanthemi (7, 13, 15, 20, 45, 46, 55) , and genes encoding (flavo)Hbs are found in diverse microbes. In contrast, infectious microbes express one of three different types of NORs; however, not all organisms employ NORs for NO detoxification (18, 64) .
Inhibitors that target the heme prosthetic group of (flavo)Hbs are attractive candidates for antibiotic development. Imidazoles bearing bulky aromatic substituents offer potential for selective and high-affinity inhibition of NOD function by coordinating the catalytic heme iron and "fitting" within the large hydrophobic distal heme pocket (11, 20, 28, 44) . Imidazole coordinates the ferric iron atom of E. coli flavoHb with an equilibrium dissociation constant (K d ) of 333 M (28), and imidazoles with bulky aromatic N-1 substituents bind and inhibit heme enzymes with similar hydrophobic pockets such as the cytochromes P450 Cyp51 (lanosterol 14␣-demethylase) and Cyp121 (2, 35, 47, 63) .
We have investigated the sensitivity of microbial NODs to imidazole derivatives at the enzymatic and cellular levels and propose a mechanism for NOD inhibition based on kinetic and spectroscopic data. Imidazole inhibition of microbial NOD is suggested as a strategy for increasing the antibiotic efficacy of immune system-derived NO.
RM1000 was grown at 37°C in YPD medium supplemented with 50 mg/liter uridine, 20 mg/liter adenine, 100 mg/liter leucine, and 20 mg/liter tryptophan to ensure maximal growth and NOD activity induction. At an A 600 of 0.25, RM1000 cultures were exposed to 960 ppm NO in an atmosphere containing 21% O 2 for 60 min (55) . S. aureus cultures were grown at 37°C with aeration in phosphatebuffered Luria broth (22) to an A 550 of 0.05 and exposed to 960 ppm NO in an atmosphere containing 21% O 2 for 120 min. Cultures were quickly chilled on ice to inhibit growth and protein synthesis, harvested, washed, and assayed for NO metabolism (22) .
For growth and viability experiments, S. cerevisiae strains were grown at 30°C in YPD medium under an atmosphere containing 21% O 2 balanced with N 2 (220 M O 2 in solution). S. cerevisiae cultures were initiated from overnight cultures with an initial A 600 of 0.06. Dimethyl sulfoxide (DMSO) was added at 0.01% (vol/vol) as the solvent for miconazole. C. albicans strains were grown at 37°C in a modified YPD medium containing 5 mM glucose under an atmosphere containing 1.05% O 2 balanced with N 2 (10 M O 2 in solution) to better mimic the physiological conditions of tissue infections. Cultures were initiated from overnight cultures with an initial A 600 of 0.04. After 30 min of initial growth, cultures were exposed to 160 ppm NO with or without 5 M econazole. DMSO was added to 0.01% (vol/vol) as the solvent for econazole. Cell density was measured by plating, colony counting, and optical density measurements (21, 55) .
RESULTS

Imidazoles inhibit microbial NODs.
Antimicrobial imidazoles were tested for their ability to inhibit the NOD activity of purified flavoHbs. As shown for the E. coli NOD activity (Fig.  1 ), a linear relationship is observed for 1/v versus [imidazole], suggesting a reversible mechanism involving imidazole binding. Miconazole, econazole, clotrimazole, and ketoconazole inhibited E. coli NOD with apparent K i values of 80, 550, 1,300, and 5,000 nM, respectively. A. eutrophus, S. cerevisiae, and C. albicans NOD activities showed similar inhibition kinetics with the exception of the A. eutrophus enzyme, which showed biphasic inhibition (data not shown). Biphasic inhibition may be due to partial retention of lipids in the hydrophobic distal heme pocket (44) or the existence of multiple conformational states. Apparent K i values for the bacterial and S. cerevisiae enzymes reveal an order of potency: miconazole Ͼ econazole Ͼ clotrimazole Ͼ ketoconazole (Table 1) . For the C. albicans enzyme, econazole was ϳ3-fold more effective than miconazole. In comparison, the potent lanosterol 14␣-demethylase inhibitor and antifungal agent itraconazole (6, 58) , bearing a triazole and bulky substituent more similar in structure to that of ketoconazole than the other imidazoles (structures reviewed in reference 58), showed a weaker inhibition more similar to that of ketoconazole. At 2 M, itraconazole inhibited C. albicans and E. coli NOD activities by 6% and 27%, respectively.
Inhibition (19, 24) and that NO inhibition was augmented by miconazole (Fig. 2B) .
Imidazoles bind oxidized and reduced flavoHb. Imidazoles were examined spectroscopically for their ability to coordinate the iron atom in E. coli flavoHb. Miconazole caused a 10-nm red shift of the Soret band ( Table 2 ) and appearance of a strong ␤-band absorbance at 537 nm with a weak shoulder at 570 nm (data not shown), indicating imidazole nitrogen coordination to produce a hexacoordinate low-spin heme iron. Miconazole also coordinated ferrous heme iron as revealed by a 6-nm blue shift and enhancement of the Soret band and by the appearance of distinct ␤ and ␣ bands at 530 and 560 nm, respectively. Econazole, clotrimazole, and ketoconazole produced similar spectral changes (Table 2) , indicating limited interference of N-1 substituents with heme iron coordination.
Only minor differences in ␣-and ␤-band maxima of the ferrous complexes were observed with ketoconazole showing the largest effects.
Miconazole showed rapid, and near stoichiometric, coordination to flavoHb-Fe(III) (Fig. 3A) . In contrast, miconazole associated weakly with the NADH-reduced ferrous form as evidenced by relatively slow coordination (data not shown) and substoichiometric formation of the Fe(II)-miconazole complex (Fig. 3B) .
Imidazole binding impedes NADH-mediated reduction of heme and FAD. NOD function requires reduction of the ferric heme in the globin domain of flavoHb via an electron shuttle from free NADH to bound FAD to the heme (19, 20) . Coordination of miconazole to the ferric heme iron inhibited heme and FAD reduction as evidenced by the slower rate of transition from the ferric to ferrous state with miconazole coordination (Fig. 4, compare (A) Miconazole was added to E. coli flavoHb-Fe(III) (4.0 M heme), and coordination was followed by measuring the absorbance differences for the maximum (417 nm) and minimum (382 nm) of difference spectra of the miconazole complex and free enzyme. (B) Miconazole was added to NADH-reduced flavoHb-Fe(II) (4.0 M heme) under anaerobic conditions. Samples were incubated for 5 min to allow coordination, difference spectra were recorded, and the absorbance difference for the peak (412 nm) and trough (437 nm) were measured. for the miconazole complex. Coordination of miconazole to the heme iron also decreased the rate of FAD reduction as measured by the change in absorbance at 460 nm (Fig. 4D) . The lower rate of FAD reduction may be explained by an allosteric effect of imidazole binding in the distal pocket on the NADH-FAD electron transfer reaction and a lower rate constant for hydride transfer (kЈ H ). Similar effects on heme and FAD reduction were observed with econazole, clotrimazole, and ketoconazole (data not shown).
Imidazoles inhibit NO metabolism in microbes.
In S. cerevisiae, C. albicans, and E. coli, Ͼ95% of the aerobic NO metabolic activity is catalyzed by the flavoHbs (25, 55) . Imidazoles were investigated for their ability to inhibit NO metabolism by intact cells. In S. cerevisiae, miconazole showed 50% inhibition of NO metabolism at 10 M (Fig. 5A) . Inhibition was rapid and progressive (Fig. 5B) , suggesting efficient uptake and accumulation within cells. Similar effects of miconazole were observed in C. albicans. Treatment of Candida with 0.5, 1, 2, 5, and 10 M miconazole inhibited the inducible NOD activity (YHB1) (55) by 33, 51, 55, 68, and 84%, respectively. The greater sensitivity of the C. albicans NOD activity correlated with the lower K i value determined for the purified enzyme (Table 1) .
Although the purified E. coli NOD activity was more sensitive to miconazole (K i ϭ 80 nM) than either the C. albicans or S. cerevisiae enzymes, NO consumption by E. coli was only modestly inhibited by miconazole and other imidazoles. E. coli expressing a level of NOD activity of 116 Ϯ 12 nmol NO/min/ 10 8 cells was inhibited by 34 Ϯ 5, 41 Ϯ 3, and 24 Ϯ 3% following incubation with 50 M miconazole, econazole, and clotrimazole, respectively. The results are consistent with the poor membrane permeability and antibiotic activity of imidazoles toward gram-negative E. coli (3, 48) . By comparison, NO metabolism in gram-positive S. aureus was more sensitive to imidazole inhibition. S. aureus expressing a basal NOD activity of 2.6 Ϯ 0.6 (n ϭ 3) nmol NO/min/10 8 cells and an induced level of activity of 6.5 Ϯ 0.2 nmol NO/min/10 8 cells (n ϭ 3) following a 120-min exposure to 960 ppm NO was rapidly inhibited by imidazoles. Miconazole, econazole, or clotrimazole (5 M) inhibited the induced NO metabolic activity by 92% Ϯ 3%, 68% Ϯ 3%, and 41% Ϯ 3%, respectively.
Effects of NO and imidazoles on S. cerevisiae and C. albicans growth. We tested the sensitivity of S. cerevisiae to miconazole with and without exposure to NO during aerobic growth in nutrient-rich YPD medium. As shown in Fig. 5 and 6A support an antibiotic mechanism for miconazole involving NOD inhibition. Nevertheless, at these relatively high miconazole concentrations, the increased NO sensitivity of S. cerevisiae could also be due in part to miconazole impairment of membrane synthesis, membrane integrity, and other cell functions (1, 30, 53, 58) . Under conditions mimicking microaerobic C. albicans infection, 160 ppm NO gas exposure (Ͻ0.3 M in solution) also showed strong inhibition of the growth of the NOD-deficient C. albicans mutant (⌬YHB1) but not the isogenic parental strain RM1000 (Fig. 6B, compare open and solid bars) . Unlike the effect of miconazole on the NO sensitivity of S. cerevisiae, econazole (5 M) did not increase the sensitivity of strain RM1000 to NO. The results suggest that econazole accumulates in C. albicans at levels that are too low to effectively inhibit NOD (K i ϭ 225 nM) but at concentrations sufficient to inhibit the sensitive lanosterol 14␣-demethylase (58) .
DISCUSSION
Mechanism of NOD inhibition. FlavoHb-type NODs possess remarkably large hydrophobic heme pockets capable of sequestering bulky aliphatic lipids (28, 44) and imidazole N-1 substituents. Indeed, the ability of large hydrophobic imidazoles (58) to inhibit NODs correlates remarkably well with the affinity of heme pockets for lipids: A. eutrophus Ͼ E. coli Ͼ S. cerevisiae (Table 1 ) (44). Furthermore, the ability of a single chlorine atom of miconazole to confer a 2.5-to 20-fold decrease in the K i value from that for econazole suggests specific interactions with the large hydrophobic N-1 substituent affecting the geometric orientation and subsequent coordination to heme iron. An exception is the C. albicans NOD, which exhibits an ϳ3-fold greater sensitivity to econazole than to miconazole ( Table 1 ). The lower sensitivity of the S. cerevisiae NOD to imidazoles in general suggests weaker interactions between the N-1 substituents and the distal hydrophobic pocket. Alternatively, certain flavoHb structures may control entry of N-1-substituted imidazoles into the heme pocket, as suggested by structural studies of the M. tuberculosis 14␣-sterol demethylase (product of CYP51) (47) . Our kinetic and spectral results suggest a mechanism for NOD inhibition involving high affinity binding of imidazoles to the flavoHb-Fe(III) intermediate (Fig. 7) (20) . Thus, uncompetitive inhibition by imidazoles, with respect to O 2 ( Fig. 2A) , reveals a mechanism of inhibition largely independent of O 2 and flavoHb-Fe(II). In contrast, CO competitively inhibits NOD with respect to O 2 by forming a high-affinity flavoHb-Fe(II) CO complex (24) . The failure of imidazoles to compete with NO (Fig. 2B ) also rules out mechanisms involving interference with the NO dioxygenation reaction (Fig. 7, reaction steps 4a and 4b) . Furthermore, increased inhibition by NO in the presence of miconazole (Fig.  2B) suggests a secondary mechanism involving increased accessibility of NO for flavoHb-Fe(II) (19) . The apparent K i values for imidazoles (Table 1) presumably reflect composite equilibrium dissociation constants with the affinity of imidazoles for flavoHb-Fe(III) being far greater than for flavoHbFe(II) (Fig. 7) . Together, the results support a mechanism in which imidazole binding to the flavoHb-Fe(III) intermediate impairs the reduction of heme and FAD (Fig. 7 , reaction steps VOL. 49, 2005 IMIDAZOLES INHIBIT NITRIC OXIDE DIOXYGENASE 1841 1, 2a, and 2b), thus limiting subsequent steps in NOD turnover. Figure 7 also predicts greater imidazole inhibition with decreased NADH availability or poor reductase coupling as reflected by a lower k ET . It is noteworthy that imidazoles also show preference for ferric heme iron in lanosterol 14␣-demethylase (63), suggesting similar mechanisms for inhibition. Antibiotic action of imidazoles and NOD inhibition. Imidazoles and triazoles inhibit the heme-dependent lanosterol 14␣-demethylase at low nanomolar concentrations and alter sterol synthesis and membrane biogenesis and stability in yeasts and fungi. Lanosterol 14␣-demethylase inhibition is responsible for the antibiotic activity of these agents towards a variety of pathogenic yeast and fungi (33, 42, 57, 58, 62, 63) . Azoles are widely used for treating various mycoses of skin, mucosa, and subcutaneous tissue. Ketoconazole, and more commonly itraconazole, and other potent triazole-based inhibitors of the lanosterol 14␣-demethylase are administered for systemic fungal infections (5, 29, 42, 48, 52, 54, 58) . In addition, antifungal imidazoles show antibacterial activity (5, 48, 49, 52, 56, 59 ), yet the antibiotic mechanisms remain to be fully elucidated.
Our results demonstrate that the NOD function of yeast, fungal, and bacterial flavoHbs can also be inhibited by antifungal imidazoles, albeit at greater than 100-fold higher concentrations than reported for the fungal and yeast lanosterol 14␣-demethylase (33, 57, 58) . Imidazoles coordinated heme and inhibited NOD activity of the purified bacterial, yeast, and fungal flavoHbs (Table 1) . Imidazoles also inhibited NOD activities in S. cerevisiae (Fig. 5) , C. albicans, and S. aureus and to a much lesser extent within E. coli. Moreover, miconazole increased NO-mediated growth inhibition of S. cerevisiae (Fig.  6A) . On the other hand, the results do not exclude a mechanism involving NO sensitization due to lanosterol 14␣-demethylase inhibition as previously suggested for clotrimazole sensitization of C. albicans to hydrogen peroxide (50) or the direct inhibition of membrane-bound ATPases and cytochrome oxidase, as well as the synthesis of mitochondrial and peroxisomal enzymes including peroxidase and catalase (8, 9, 30) . Indeed, antibiotic synergy between imidazoles and NO-releasing diazeniumdiolates was previously reported for Candida (34) and may also be explained by NOD-independent mechanisms since the agents inhibited NOD weakly. Furthermore, the expression of inducible pumps for imidazole removal (58, 60) coupled with relatively high K i values (Table 1 ) may preclude econazole and other imidazoles from effectively inhibiting NOD activity in C. albicans and other organisms.
Nevertheless, the potency of NO as an antibiotic in the absence of NOD (Fig. 6) (20) and the sensitivity of NODs to imidazoles (Table 1) encourage the search for imidazoles that more effectively inhibit NOD function. Knowledge of flavoHbFe(III)-imidazole structures and the availability of a rich pharmacopoeia of imidazoles and triazoles for testing should facilitate the identification and design of more efficacious NOD inhibitors. The unique sensitivity of the bacterial NODs to miconazole also motivates investigations of synergy between NO, miconazole, and antibacterial agents such as polymyxin B that can increase the penetration of miconazole through E. coli membranes (3).
